CD8A and myeloid sarcoma: Flow cytometrical and immunohistochemical examinations of fresh autopsy materials from MS patients revealed that CD8+ T cells isolated from lesions exhibited surface markers typical of TRM, including CD69, CD103, PD‐1, VLA‐1, and CD49a [72, 73].